About US
Contact us
-
FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritisChelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has2010/8/27
-
FDA notification confirms acyclovir Lauriad for oro-facial herpes labialisRegulatory News: “This notification from the FDA confirms that acyclovir Lauriad® represents an innovation in the treatment of oro-facial herpes labialis and strengthens our position to find the2010/8/27
-
FDA to Priority Review Bristol-Myers Squibb Melanoma DrugBristol-Myers Squibb has received confirmation that the US Food and Drug Administration (FDA) has accepted its biologics licence application for ipilimumab for filing and review. The company also an2010/8/26
-
Commissioner Shao Mingli meets Director of Singapore Health Sciences AuthorityOn August 17, 2010, Shao Mingli, commissioner of the State Food and Drug Administration, met the visiting Dr John Lim, Director of Singapore Health Sciences Authority and his party. Both parties discu2010/8/26
-
Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalificationThe World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children fro2010/8/25
-
Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide TherapeuticsAileron Therapeutics and Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Pep2010/8/25
-
FDA approves Alexion's Rhode Island manufacturing facility as commercila supply source for SolirisAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the US Food and Drug Administration (FDA) has approved Alexion's Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Is2010/8/24
-
BASF to build dispersions plant in Huizhou to better serve growing markets in South China· Strengthens BASF’s commitment to Asia’s fast-growing paper markets, especially China · Supports anticipated growth in the region’s coatings, construction, printing & packaging and adhesives2010/8/24
-
USPTO to allow patent for Advaxis’s new vaccine technologyAdvaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has been notified that the US Patent and Trademark Office (USPTO) will allow a patent issu2010/8/23
-
WHO calls upon countries to be alert to antimicrobial resistanceBe alert to antimicrobial resistance Antimicrobial resistance (AMR) - the ability of micro-organisms to find ways to evade the action of the drugs used to cure the infections they cause - is increasi2010/8/23